Editorial & Opinion

High cost oncology drugs without proof of added benefit are burdening health systems.

التفاصيل البيبلوغرافية
العنوان: High cost oncology drugs without proof of added benefit are burdening health systems.
المؤلفون: Brinkhuis F; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Goettsch WG; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.; National Health Care Institute, Diemen, Netherlands., Mantel-Teeuwisse AK; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands., Bloem LT; Division of pharmacoepidemiology and clinical pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands.
المصدر: BMJ (Clinical research ed.) [BMJ] 2024 Feb 29; Vol. 384, pp. q511. Date of Electronic Publication: 2024 Feb 29.
نوع المنشور: Editorial
اللغة: English
بيانات الدورية: Publisher: British Medical Association Country of Publication: England NLM ID: 8900488 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-1833 (Electronic) Linking ISSN: 09598138 NLM ISO Abbreviation: BMJ Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London : British Medical Association
مواضيع طبية MeSH: Medical Oncology* , Drug Costs*, Humans ; Cost-Benefit Analysis
مستخلص: Competing Interests: Competing interests: All authors have completed the ICMJE uniform disclosure form at https://icmje.org/disclosure-of-interest/ and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work.
تواريخ الأحداث: Date Created: 20240229 Date Completed: 20240304 Latest Revision: 20240328
رمز التحديث: 20240329
DOI: 10.1136/bmj.q511
PMID: 38423553
قاعدة البيانات: MEDLINE
الوصف
تدمد:1756-1833
DOI:10.1136/bmj.q511